Secreted proteins of Neisseria meningitidis protect mice against infection

Vaccine

Volumn 27, Issue 17, 2009, Pages 2320-2325

  Li, Yanwen ^a   Wooldridge, Karl G ^b   Javed, Muhammad A ^b   Tang, Christoph M ^a   Ala'Aldeen, Dlawer A A ^b  

^a Faculty of Medicine   (United Kingdom)

^b Institute of Infection Immunity and Inflammation   (United Kingdom)

Author keywords

Bactericidal assay; Host immune response; Invasive meningococcal disease; Meningitis; Meningococcus; Vaccine

Indexed keywords

ANTISERUM; BACTERIAL PROTEIN; FREUND ADJUVANT; LIVE VACCINE; MENINGOCOCCAL SECRETED PROTEIN; MENINGOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; BACTERIOLYSIS; BAGG ALBINO MOUSE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; IMMUNITY; MENINGOCOCCOSIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL PROTEINS; BACTERIOLYSIS; FEMALE; IMMUNE SERA; IMMUNIZATION SCHEDULE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS, SEROGROUP B; SERUM BACTERICIDAL TEST;

EID: 62549146272     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.034     Document Type: Article

References (34)

1. Ala'Aldeen D.D.A., Neal K.R., Ait-Tahar K., Nguyen-Van-Tam J.S., English A., Falla T.J., et al. Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol 38 6 (2000) 2311-2316
2. Neal K.R., Nguyen-Van-Tam J.S., Jeffrey N., Slack R.C., Madeley R.J., Ait-Tahar K., et al. Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. BMJ 320 7238 (2000) 846-849
3. Caugant D.A., Bol P., Hoiby E.A., Zanen H.C., and Froholm L.O. Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986. J Infect Dis 162 4 (1990) 867-874
4. Caugant D.A., Mocca L.F., Frasch C.E., Froholm L.O., Zollinger W.D., and Selander R.K. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol 169 6 (1987) 2781-2792
5. Cartwright K.A., and Ala'Aldeen D.D.A. Neisseria meningitidis: clinical aspects. J Infect 34 1 (1997) 15-19
6. Pichichero M., Casey J., Blatter M., Rothstein E., Ryall R., Bybel M., et al. Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y and W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children. Pediatr Infect Dis J 24 1 (2005) 57-62
7. Bjune G., Hoiby E.A., Gronnesby J.K., Arnesen O., Fredriksen J.H., Halstensen A., et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338 8775 (1991) 1093-1096
8. Sierra G.V., Campa H.C., Varcacel N.M., Garcia I.L., Izquierdo P.L., Sotolongo P.F., et al. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann 14 2 (1991) 195-207 (discussion. 08-10)
9. Tappero J.W., Lagos R., Ballesteros A.M., Plikaytis B., Williams D., Dykes J., et al. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA 281 16 (1999) 1520-1527
10. Peeters C.C., Rumke H.C., Sundermann L.C., Rouppe van der Voort E.M., Meulenbelt J., Schuller M., et al. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 14 10 (1996) 1009-1015
11. Giuliani M.M., Adu-Bobie J., Comanducci M., Arico B., Savino S., Santini L., et al. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci USA 103 29 (2006) 10834-10839
12. Robinson K., Taraktsoglou M., Rowe K.S., Wooldridge K.G., and Ala'Aldeen D.D.A. Secreted proteins from Neisseria meningitidis mediate differential human gene expression and immune activation. Cell Microbiol 6 10 (2004) 927-938
13. Li Y., Sun Y.H., Ison C., Levine M.M., and Tang C.M. Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci. Infect Immun 72 1 (2004) 345-351
14. Scholten R., Kuipers B., Valkenburg H., Danker J., Zollinger W., and Poolman J. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J Med Microbiol 41 (1994) 236-243
15. Wooldridge K.G., Kizil M., Wells D.B., and Ala'Aldeen D.D.A. Unusual genetic organization of a functional type I protein secretion system in Neisseria meningitidis. Infect Immun 73 9 (2005) 5554-5567
16. Hadi H.A., Wooldridge K.G., Robinson K., and Ala'Aldeen D.D.A. Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis. Mol Microbiol 41 3 (2001) 611-623
17. Turner D., Marietou A., Johnston L., Ho K., Rogers A., Wooldridge K., et al. Characterisation of MspA-an immunogenic autotransporter protein mediating adhesion to epithelial and endothelial cells in Neisseria meningitidis. Infect Immun 74 5 (2006) 2957-2964
18. Turner D.P., Wooldridge K.G., and Ala'Aldeen D.D.A. Autotransported serine protease A of Neisseria meningitidis: an immunogenic, surface-exposed outer membrane, and secreted protein. Infect Immun 70 8 (2002) 4447-4461
19. Ulsen P., and Tommassen J. Protein secretion and secreted proteins in pathogenic Neisseriaceae. FEMS Microbiol Rev 30 2 (2006) 292-319
20. Pohlner J., Halter R., Beyreuther K., and Meyer T.F. Gene structure and extracellular secretion of Neisseria gonorrhoeae IgA protease. Nature 325 6103 (1987) 458-462
21. Peak I.R., Srikhanta Y., Dieckelmann M., Moxon E.R., and Jennings M.P. Identification and characterisation of a novel conserved outer membrane protein from Neisseria meningitidis. FEMS Immunol Med Microbiol 28 4 (2000) 329-334
22. van Ulsen P., van Alphen L., ten Hove J., Fransen F., van der Ley P., and Tommassen J. A Neisserial autotransporter NalP modulating the processing of other autotransporters. Mol Microbiol 50 3 (2003) 1017-1030
23. Ait-Tahar K., Wooldridge K.G., Turner D.P., Atta M., Todd I., and Ala'Aldeen D.D.A. Auto-transporter A protein of Neisseria meningitidis: a potent CD4+ T-cell and B-cell stimulating antigen detected by expression cloning. Mol Microbiol 37 5 (2000) 1094-1105
24. Parkhill J., Achtman M., James K.D., Bentley S.D., Churcher C., Klee S.R., et al. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature 404 6777 (2000) 502-506
25. Schmitt C., Turner D., Boesl M., Abele M., Frosch M., and Kurzai O. A functional two-partner secretion system contributes to adhesion of Neisseria meningitidis to epithelial cells. J Bacteriol 189 22 (2007) 7968-7976
26. Caugant D., Bøvre K., Gaustad P., Bryn K., Holten E., Høiby E., et al. Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J Gen Microbiol 132 (1986) 641-652
27. Maiden M.C., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 95 6 (1998) 3140-3145
28. McGuinness B.T., Clarke I.N., Lambden P.R., Barlow A.K., Poolman J.T., Jones D.M., et al. Point mutation in meningococcal por A gene associated with increased endemic disease. Lancet 337 8740 (1991) 514-517
29. Pizza M., Scarlato V., Masignani V., Giuliani M.M., Arico B., Comanducci M., et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287 5459 (2000) 1816-1820
30. Wang J.F., Caugant D.A., Morelli G., Koumare B., and Achtman M. Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis 167 6 (1993) 1320-1329
31. Rokbi B., Renauld-Mongenie G., Mignon M., Danve B., Poncet D., Chabanel C., et al. Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine. Infect Immun 68 9 (2000) 4938-4947
32. Virji M., Saunders J.R., Sims G., Makepeace K., Maskell D., and Ferguson D.J. Pilus-facilitated adherence of Neisseria meningitidis to human epithelial and endothelial cells: modulation of adherence phenotype occurs concurrently with changes in primary amino acid sequence and the glycosylation status of pilin. Mol Microbiol 10 5 (1993) 1013-1028
33. Poolman J.T., Hopman C.T., and Zanen H.C. Colony variants of Neisseria meningitidis strain 2996 (B:2b:P1.2): influence of class-5 outer membrane proteins and lipopolysaccharides. J Med Microbiol 19 2 (1985) 203-209
34. Achtman M., Wall R.A., Bopp M., Kusecek B., Morelli G., Saken E., et al. Variation in class 5 protein expression by serogroup A meningococci during a meningitis epidemic. J Infect Dis 164 2 (1991) 375-382